initi coverag
price apr
multipl yield calcul use averag histor price past year spot price current futur year except price-to-book use
year end close
distribut gmt
deutsch bank seek busi compani cover research report thu investor
awar firm may conflict interest could affect object report investor
consid report singl factor make invest decis disclosur analyst
reason entri point market
leader strong momentum
initi buy multipl expans justifi earn outlook
initi coverag tp buy rate
posit outlook earn growth driven
continu strong demand product increas penetr current
market market share gain support product develop
expans new market trade histor averag pe
believ deserv re-rat given strong earn
momentum potenti upgrad consensu estim forecast
deliv ep compound-annual-growth-rate next year offer tsr
strong growth across region
deliv strong constant currenc sale growth
underli ebit growth compani revenu growth
occur across segment growth america devic
growth america mask accessori growth rest world devic
growth rest world mask accessori
potenti upgrad consensu estim
see upsid risk consensu estim npat
forecast ahead consensu number npat forecast
ahead consensu number
tp deriv use dcf valuat
methodolog dcf use wacc coe d/ev tv
downsid risk includ advers chang reimburs
run number
global
develop
manufactur distribut market medic
devic cloud-bas softwar applic
diagnos treat manag respiratori disord xd
flow oper
net inc/ dec borrow
chang work capit
cash equival
 tax effect
board director
initi coverag tp buy rate
global leader develop manufactur distribut
market medic devic cloud-bas softwar applic
diagnos treat manag sleep apnea respiratori disord
posit outlook earn growth driven
continu strong demand product increas penetr current
market market share gain support product develop
expans new market
deliv strong constant currenc sale growth
underli ebit growth compani revenu growth
occur across segment growth america devic
growth america mask accessori growth rest world devic
growth rest world mask accessori
compani strong balanc sheet leverag strong cash
convers ratio continu invest undertak capit
manag make strateg acquisit
like compani market lead posit high cash convers low
capit intens high roe
forecast revenu ebit growth npat
expect increas due advers tax chang
see upsid risk consensu estim npat
forecast ahead consensu number npat forecast
ahead consensu number
forecast offer ep compound-annual-growth-rate next year
dividend yield stock trade premium asx
industri ex bank histor averag howev believ
stock deserv re-rat given strong earn momentum
upsid risk consensu estim forecast target price impli
tp base dcf valuat use three-stag
dcf model discount post-tax free cash flow
wacc assum beta coe risk-fre rate
premium target d/ev forecast explicit cash flow
follow horizon period cash flow growth fade
long-term termin valu growth rate set termin
growth rate slight premium nomin global estim reflect
long term demand trend rmd osa product
deutsch bank estim bloomberg financ lp consensu estim compani price april forward period estim
trade mth forward pe premium
asx industri ex bank compar histor averag
premium believ stock trade upper end trade
rang given forecast ebit growth histor averag
signific reduct product fund reimburs
new innov product releas competitor lead market
elev price pressur increas competit
global leader develop manufactur distribut
market medic devic cloud-bas softwar applic
diagnos treat manag sleep apnea respiratori disord
portfolio product includ devic diagnost product mask system
headgear accessori dental devic portabl oxygen concentr
cloud-bas softwar informat solut
compani devic predominantli use home lesser
extent gener hospit ward respiratori ward
compani market product countri sleep clinic
home healthcar dealer patient third-parti payor compani sell
product network distributor direct sale forc
compani employ approxim peopl
employ wareh manufactur sale
market administr
compani revenu split
devic revenu air flow gener ventil
mask accessori revenu diagnost product
mask system headgear dental devic accessori
brightre revenu cloud-bas softwar informat
compani geograph revenu split north latin america
europ asia pacif
form commerci treatment osa
treatment nasal continu posit airway pressur cpap first
success non-invas treatment osa origin organ
acquir right certain technolog relat cpap treatment
baxter well baxter exist cpap devic busi
move headquart san diego california juli
compani list ipo septemb
list transfer new york stock exchang nyse
novemb also went secondari list
depositari instrument cdi australian stock exchang cdi
asx repres one share common stock nyse
biancam develop sleep breath medic equip
alreadi investor compani acquisit saw buy
remain stake compani acquisit gain access
biancam flagship sleep monitor product sleepmind
august acquir umbian inc provid innov web-
base healthcar softwar solut canada acquisit
gain access u-sleep provid comprehens patient complianc
decemb strengthen emerg market focu acquir
czech-bas unimedi lead distributor equip treatment
sleep disordered-breath czech republ slovakia
februari acquir jaysec us-bas provid internet-
base softwar solut home medic equip hme provid
jaysec close hme custom us also includ
juli acquir cur medic lead provid non-
invas ventil sleep-disord breath medic devic
accessori grow chines market acquisit
becam market leader sleep-disord breath respiratori care
china
novemb acquir maribo medico market leader sleep
respiratori care denmark exclus distribut partner
denmark year
januari strengthen respiratori care portfolio
acquir inova lab inc special develop
commerci innov oxygen therapi product treatment
april acquir brightre provid busi manag
clinic softwar applic medic equip home health
resm hold limit found dr peter farrel
resm inc form hold compani
list ipo
transfer princip list nyse
went secondari list asx
acquir czech-bas unimedi part emerg market expans
acquir jaysec provid internet-bas softwar solut hme
aquir caretouch leader resuppli solut hme provid
acquir cur medic expand chines market
acquir maribo medico market leader sleep respiratori care
acquir inova lab strengthen respiratori care portfolio
acquir brightre llc gain access post-acut care industri
report oper product offer geograph region
figur revenu product
figur revenu region
 april
manufactur oper consist primarili assembl test devic
mask accessori raw materi part compon
purchas assembl off-the-shelf item avail multipl vendor
howev purchas uniqu configur compon
compani gener manufactur intern sale forecast fill
order receiv
resm manufactur facil locat sydney australia loyang
singapor chatsworth california johor bahru malaysia atlanta
georgia major manufactur undertaken singapor
ventil product astral activox lumi lumi st-a
recent launch airtouch mask product featur use
memori foam receiv strong patient take-up
also recent launch mobi first brand portabl oxygen
sale process vari geograph region
north america latin america rmd product typic
purchas home healthcar dealer sell product
patient sale market activ conduct
field sale organ sell product home healthcar
dealer branch locat howev also market product
directli physician sleep clinic refer patient
europ wholly-own subsidiari number
european countri compani use independ distributor
countri undertak direct sale mani
countri europ sell product home healthcar
dealer hospit sell product patient
asia pacif use combin direct sale forc
independ distributor sell product asia pacif
cost medic care mani countri oper
fund substanti part govern privat insur program
airsolut provid comprehens solut treat sleep-disord
breath cover stage patient pathway airsolut
portfolio includ product airsens aircurv lumi airview myair
devic togeth help creat eco-system connect
relat stakehold physician sleep lab home medic equip
provid patient address pain point compani launch
airsolut platform august
airview cloud-bas patient manag system offer
healthcar provid remot access patient devic monitor
adjust therapi set requir airview softwar current patient
popul supervis compani launch airview
platform august
april acquir brightre llc suppli busi
manag softwar servic medic equip home health
resm strategi expand busi oper capit
growth sdb respiratori care market consist
continu product develop innov approxim
compani employe devot activ
compani invest revenu
expand geograph presenc compani market product
countri compani intend increas sale
market effort princip market well expand
depth presenc high-growth geograph region includ
china india eastern europ brazil southeast asia
increas public clinic awar continu expand
promot activ increas awar sdb copd
clinic condit promot activ target
popul predispos sdb medic specialist special
expand new clinic applic continu seek identifi
new applic technolog signific unmet medic
compani growth horizon
first horizon includ exist market osa treatment
second horizon includ use connect devic
treatment respiratori failur hospit home
third horizon focus portfolio new market option
includ sleep consum well connect care expans
continu drive effici within healthcar ecosystem
clinic area interest adjac market like atrial fibril heart
failur asthma
august fisher paykel healthcar fph announc
su variou alleg patent infring
august fph file patent infring proceed
us district court central district california involv
swift brand mask
respond two day later august request san diego court
invalid declar non-infring fph patent part rmd
respons compani also file patent infring proceed
fph number jurisdict
unit state us district court southern district
california involv patent relat fph simplu eson
osa mask addit sought hear itc
germani district court munich enter preliminari
injunct stop sale eson simplu outcom
fph appeal possibl christma
nz also ask nz high court stop
manufactur export infring mask new zealand
total us health expenditur reach trillion repres
base current
expenditur grow averag rate annual
reach trillion would faster current project annual
increas
deutsch bank depart commerc
us healthcar spend growth slow increas
growth follow implement afford act
us privat health insur estim paid
health expenditur follow medicar medicaid
respect hospit repres expenditur
follow prescript drug cost physicians/clin staff
figur total nhe fund
figur total us health expenditur servic
expenditur bln gdpnation expenditur y/yout insur third parti clinicaldent servicesoth profession serviceshom carenon-dur medic productsprescript drugdur medic equip april
center medicar medicaid servic
medicar feder govern program provid health care coverag
either peopl age disabl medicar divid
home health hospic care
medicar part cover almost reason necessari medic
servic includ doctor servic laboratori x-ray servic
servic outpati hospit care home health care blood
medicaid provid health care coverag low incom peopl
administ state accord feder requir medicaid jointli
fund state feder govern
patient protect afford act
patient protect afford act enact march
creat ensur american access afford health
insur expand scope peopl abl access health
insur medicaid made health insur afford
certain peopl provis tax credit creat exchang
allow easier purchas health insur also chang
rule insur compani follow
medicar prescript drug improv modern act
medicar prescript drug improv modern act
mma enabl privat health plan approv medicar
becom known medicar advantag plan plan sometim
call part plan
protect access medicar act
june publish final rule implement protect access
medicar act pama intend establish market-bas
price lab test cover clinic laboratori fee schedul clf
use volume-weight averag privat payer reimburs
volume-weight price diagnost test like meaning
lower current reimburs level mean pama result
clf price cut across lab test industri pama schedul
implement januari project save associ
pama price cut first year alon actual
percentag cut still determin base data submiss
januari american clinic laboratori associ file lawsuit
act secretari us depart
servic challeng process center medicar
medicaid servic set laboratori test price pama
earn pressur implement pama could lead industri
consolid smaller laboratori unabl absorb price reduct
durabl medic equip prosthet orthot suppli
dmepo competit bid program mandat congress
medicar prescript drug improv modern act
improv effect medicar
methodolog set dmepo payment amount reduc beneficiari
out-of-pocket expens save medicar program money ensur
beneficiari access qualiti item servic
statut requir medicar replac current fee schedul payment
methodolog select dmepo item competit bid process
program supplier submit bid provid certain medic
equip suppli peopl medicar live visit
competit bid area medicar use bid set amount pay
item bid price combin composit score cut
price establish base estim suppli demand area
bidder cutoff price evalu qualiti pass
inspect panel evalu offer agreement becom
supplier contract supplier must agre accept assign claim
bid item paid singl payment amount amount deriv
median win bid item
supplier thoroughli screen make sure meet medicar
requir elig financi qualiti accredit standard
award contract
implement competit bid program requir
law re-compet contract least everi three year addit
requir roll competit bid process nation
adjust price non-competit bid area also known non-bid
round area match competit bid price
sleep-disord breath sdb encompass diseas process
caus abnorm breath pattern sleep obstruct sleep apnea
osa common form sdb
osa occur patient repeat episod partial complet
obstruct throat upper airway sleep lead reduc
breath lower blood oxygen concentr level impair sleep qualiti
addit osa recogn caus hypertens
signific co-morbid heart diseas stroke diabet
long-term epidemiolog studi publish estim
adult age year form obstruct sleep apnea
unit state alon would repres approxim million
despit high preval osa gener lack awar
amongst medic commun gener public estim
less osa diagnos treat
resm estim less market penetr north america
less market penetr europ less market
penetr asia
continu posit airway pressur cpap devic non-invas
mean treat osa cpap treatment patient sleep nasal
interfac connect small portabl air devic deliv room air
posit pressur patient breath air devic breath
exhaust port interfac continu air pressur appli
manner act pneumat splint keep upper airway open
unobstruct cpap cure therefor must use nightli
basi long treatment requir
osa market size player
estim osa market grown
compound-annual-growth-rate
histor osa market servic three largest osa devic
manufactur philip fisher paykel healthcar
estim market share philip market
share fisher paykel market share
figur select osa mask product
airsens elit cpap launch aug
point group
revenu abl deliv high singl digit low doubl digit
revenu growth except due us reimburs chang
impact us competit bid program launch new competitor
product rumor new sleep flow gener constrain
sale exist product forecast compani achiev high singl
digit constant currenc revenu growth mid-singl digit
constant currenc revenu growth
ebitda margin remain fairli stabl compani gener
asp declin year abl off-set price declin
manufactur procur effici gross margin declin
off-set reduct sg
percentag sale assum compani abl maintain
ebitda margin perpetu
net interest compani maintain conserv net cash posit
tax effect tax rate expect increas due
implement draft australian tax chang forecast tax rate
increas manufactur tax incent roll-off
guidanc manag provid guidanc
gross margin remaind year broadli consist
sg expens rang
 expens vicin
effect non-gaap tax rate
share buy-back recomm
dp compani start pay dividend compani
histor paid ep pay nomin dp amount
next quarter
asset cash equival
trade receiv
properti plant equip
trade payabl
point balanc sheet
compani maintain conserv net cash posit
recent us tax chang greater flexibl
repatri cash off-shore locat use growth
current asset valu relat inventori
net chang cash
point cash flow
compani cash convers ratio fluctuat period due
time inventori build work capit releas
forecast cash convers ratio
capital-expenditure intens low sale
assum continu buy-back share
mick farrel appoint ceo march join
compani serv presid america region
senior vice presid global sleep apnea busi unit
variou senior role market busi develop
manag consult
biotechnolog chemic metal manufactur arthur littl
genzym corpor part sanofi chemic compani
bhp billiton mick serv board director advanc
medic technolog associ advam zimmer biomet nyse
multibillion dollar public compani provid implant musculoskelet
medic devic patient global
rob dougla presid chief oper offic
robert dougla appoint presid march chief
oper offic septemb togeth chief execut
offic mick farrel hold full oper respons
subsidiari previous rob chief oper offic asia
pacif global suppli chain respons
region commerci distribut sale oper global manufactur
sydney chief oper offic respons
compani manufactur research develop vice presid
oper respons compani manufactur
vice presid respiratori cardiac busi
vice presid corpor market join
david pendarvi appoint chief administr offic global
gener counsel may addit role serv interim
presid emea japan region march august
join global gener counsel septemb
corpor secretari sinc februari serv
senior vice presid organis develop join
david partner law firm gray cari ware freidenrich
llp specialis intellectu properti
gener busi litig partner gibson
dunn crutcher llp law clerk
lawrenc irv us district judg southern district california david
elect board director compani
decemb also serv board director san diego
region chamber commerc sinc corpor director
forum sinc director board
brett sandercock appoint chief financi offic januari
previous serv vice presid treasuri financ
novemb decemb group account control
join brett manag
account group report norton abras divis saint-
gobain french multi-national corpor also held
financ account role health australia
larg privat hospit oper work
pricewaterhous cooper sydney special audit client across
distribut manufactur financi servic technolog
jim hollingshead appoint presid sleep busi juli
previous serv presid compani america region
begin march join compani vice presid
strategi busi develop role expand includ
leadership resm ventur initi unit respons
grow early-stag busi join jim spent year
strategi consult work senior execut across wide
rang industri mainli biotech high tech telecommun
senior partner strategi life scienc
practic deloitt consult base san francisco jim
west coast manag partner monitor group lead global strategi
consult firm work variou offic around world success
launch run three differ practic includ london-bas pan-
european market strategi practic jim current sit board
sleepscor lab joint ventur pegasu capit oz
media aim creat consum marketplac scientif valid
sleep solut like
richi mchale appoint presid respiratori care busi
juli previous serv compani chief human resourc
offic begin novemb join director
unit kingdom busi team lead strong growth region richi
year experi life scienc sector work primarili
role within pharmaceut biotechnolog medic
technolog compani prior join manag director
ucb pharma unit kingdom ireland busi unit also serv
chair european medicin group member board
manag associ british industri abpi
raj sodhi presid saa busi healthcar informat
raj sodhi appoint presid softwar servic saa
busi juli ad current role presid healthcar
informat appoint previous vice
presid global healthcar informat team help build hi
strength lead current stand world lead compani
remot patient monitor expand portfolio device- saas-
base offer join acquisit umbian
inc co-found presid umbian
raj work financi servic industri design develop
manag saa solut senior vice presid busi
develop chief technolog offic skipjack financi servic
co-found chief technolog offic transact
e-commerce solut
katrin pucknat chief execut offic resm healthcar germani
katrin pucknat appoint chief execut offic resm healthcar
germani juli resm healthcar german homecar provid
servic patient sleep-disord breath copd chronic
respiratori diseas join recent serv vice
presid busi transform resm european asia pacif
region director resm european sleep-disord breath busi
variou role manag function within resm healthcar germani
includ patient servic field offic consum busi katrin
year experi medic devic segment
particular focu function market commun busi
innov busi develop join held
variou senior execut global market role medic devic compani
unit state europ
justin leong appoint senior vice presid growth market
asia includ china india may join
vice presid global strategi ad role gener manag
greater china join justin director
london-bas invest firm hgcapit respons
acquisit portfolio manag serv board director
sever european healthcar compani
manag consult bain co sydney boston new york
advis client growth strategi oper improv
project merger acquisit
nupur bhushan appoint chief human resourc offic juli
respons link employe corpor
strategi across countri employe
year hr experi high tech life scienc industri across
multipl geographi cultur previous serv vice
presid global reward mobil prior join
nupur ibm asia-pacif compens benefit director respons
reward strategi design across countri employe
also serv truste director superannu fund
hemanth reddi appoint chief strategi offic septemb
respons compani global corpor strategi corpor
develop function prior join hemanth strategi
consult year advis rang issu includ corpor
strategi busi unit strategi portfolio strategi inorgan growth
strategi across consum product high tech biotech industri
recent princip monitor deloitt deloitt consult
strategi practic co-lead san francisco offic prior deloitt
partner monitor group co-l corpor financ activ
north america share leadership respons monitor merger
acquisit advisori practic monitor group invest
banker lufkin jenrett dlj new york advis
client structur execut debt equiti offer well
carlo nunez appoint chief medic offic
januari prior join senior vice presid medic
affair becton dickinson compani lead offic scienc
medicin technolog largest divis chief
medic offic carefus built led global team
provid company-wid medic oversight carlo
chief physician execut pici inc industry-lead medic informat
compani becam part optum divis unitedhealth group
picis/optum carlo provid medic leadership clinic direct
custom relat global market work med-tech
industri carlo practic anesthesiologist intensivist hospitalist
director critic care research informat analyt duke
univers educ affili carolina medic center northeast
andrew price appoint presid global oper juli
join recent serv presid
innov oper also serv varieti senior leadership
role compani includ senior vice presid global manufactur
logist vice presid market asia pacif vice presid
product develop market compani sleep-disord
breath busi unit join design engin hold
number patent grant world-wide prior join andrew held
product develop role sunbeam consum applianc manufactur
aristocrat leisur industri one world lead provid
board director
peter farrel founder chairman board
chairman director sinc incept june dr farrel also
serv chief execut offic juli decemb
februari march dr farrel serv execut chairman
board decemb februari march
decemb sinc januari non-offic
employe juli june dr farrel serv vice
presid research develop variou subsidiari baxter
inc august june also serv
manag director baxter center medic research pti ltd baxter
subsidiari januari decemb foundat director
graduat school biomed engin univers new
south wale current serv visit professor
chairman unsw centr innov entrepreneurship also
serv visit committe health scienc technolog
program massachusett institut technolog mit dean
engin advisori council sinc dr farrel director
inc nasdaq-list compani develop market
product surgic treatment spine disord
non-execut chairman board qrx pharma
specialti pharmaceut compani dr farrel fellow honorari fellow
sever profession bodi includ member nation
academi engin elect
mick farrel appoint ceo march join
compani serv presid america region
senior vice presid global sleep apnea busi unit
variou senior role market busi develop
manag consult
biotechnolog chemic metal manufactur arthur littl
genzym corpor part sanofi chemic compani
bhp billiton mick serv board director advanc
medic technolog associ advam zimmer biomet nyse
multibillion dollar public compani provid implant musculoskelet
medic devic patient global
ron taylor serv director sinc januari independ lead
director sinc juli chair nomin govern
committe member compens committe mr taylor
found pyxi corpor manufactur autom drug dispens
hospit serv chairman presid chief execut offic
purchas cardin health inc six year
found pyxi mr taylor respons oper intern
sale hybritech inc biotechnolog compani join hybritech
serv year manag role allergan plc nyse list
pharmaceut compani mr taylor director allergan plc
serv member red lion hotel govern
compens audit committe appoint
board serv chairman foundat mr
taylor receiv univers saskatchewan
univers california irvin mr taylor background reflect signific
execut oper experi publicly-held medic technolog
pharmaceut compani includ experi evalu
invest healthcar compani partner ventur capit firm
public compani govern experi director
approxim public privat held compani past year
addit year experi member red
lion hotel govern compens audit committe
year experi member allergan audit compens
ms burt princip burt-hilliard invest sinc
sinc januari serv oper council conson capit
partner new york-bas privat equiti firm focus healthcar
industri ms burt formerli execut wellpoint inc anthem
inc serv recent wellpoint senior
vice presid corpor financ develop time wellpoint
ms burt respons among thing corpor strateg plan
execut merger acquisit strateg invest financ
treasuri real estat manag addit wellpoint financi
servic intern insur busi unit report
join wellpoint ms burt senior vice presid financ treasur
spent year chase secur inc jp morgan recent
founder manag director head healthcar invest bank
group ms burt serv board wellcar health plan inc publicly-
held manag care compani focus government-sponsor healthcar
program includ medicar medicaid plan envis healthcar
medic transport servic comprehens patient care manag
ms burt chair wellcar compens committe serv audit
financ nomin govern committe also serv
envis audit financ execut committe chair nomin
govern committe previous ms burt serv board
vanguard health system inc transit hospit corpor ms
burt graduat magna cum laud univers houston earn
bachelor busi administr
ms drexler current ceo board member sandston diagnost
consum diagnost compani sandston keyston product trak
fda-clear system home male fertil test track ms drexler
extens oper entrepreneuri experi med-tech
digit health held variou posit market sale manufactur
busi develop research develop lifescan glucos
monitor compani play key role sale lifescan johnson
 johnson ms drexler found ran amira medic inc anoth
pioneer field glucos monitor sale roch diabet
name femal entrepreneur year stevi
award entrepreneuri woman year silicon valley
women fund ms drexler also serv numer privat
compani board field diagnost medic devic digit
health sinc board chair hygieia privat digit
insulin therapi compani she also board member for-profit
subsidiari non-profit women health compani provid
increas access medicin ms drexler activ mentor advisor
astia global non-profit support high potenti femal founder
found member astia angel network individu investor
fund founder ms drexler also lead mentor startx
stanford univers incub advisori board keller center
innov engin educ princeton univers school
engin ms drexler receiv stanford univers
 chemic engin princeton univers
gari pace year experi
develop commerci advanc life scienc relat
technolog span biotechnolog pharmaceut medic devic
food industri serial entrepreneur held senior posit
small large-scal life scienc ventur compani australia
usa europ also long-term board level experi multi-
billion ad small cap compani depth knowledg aspect
technic oper compens corpor govern dr pace
contribut develop biotechnolog industri
honorari univers appoint industri govern committe
award centenari medal australian govern servic
australian societi research develop director year
corpor govern san diego director forum dr pace current
director pacira pharmaceut inc transit
inc tthi well sever privat compani dr
pace hold sc hon univers new south wale
ph massachusett institut technolog
fulbright fellow gener food scholar also held visit
academ posit massachusett institut technolog
univers queensland dr pace elect fellow australian
academi technolog scienc engin
rich sulpizio serv director sinc august chair
compens committe mr sulpizio retir presid
inc serv board director
mr sulpizio join
appoint presid qualcomm wireless busi solut four year
later becam presid re-join
serv interim presid china took
helm qualcomm europ appoint presid
mediaflo usa inc wholly-own subsidiari
charter overse develop deploy mediaflo
technolog bring multimedia servic wireless industri mr
sulpizio last assign decemb novemb
presid ceo qualcomm enterpris servic qe divis
inc sold privat equiti firm join
mr sulpizio work unisi corpor
mr sulpizio current serv director ca inc inform
technolog manag softwar compani also serv honorari
board member advisori board univers california san diego
sulpizio famili cardiovascular center mr sulpizio hold california
state univers lo angel system manag
univers southern california mr sulpizio background reflect signific
execut oper experi publicly-held
compani includ servic presid chief oper offic
seven year member board strateg
committe addit mr sulpizio also serv chair compens
committe member govern committe
corpor director forum honor mr sulpizio director
year corpor govern
john wareham serv director sinc januari septemb
januari mr wareham presid beckman coulter
develop market
instrument chemistri softwar suppli simplifi autom
laboratori process mr wareham also serv chief execut offic
august februari chairman januari april
join beckman coulter mr wareham presid
norden laboratori inc wholly-own subsidiari smithklin beckman
first join predecessor smithklin beckman corpor mr
wareham director non-execut chairman steri corpor
nyse-list market leader infect prevent decontamin health
scienc technolog product servic mr wareham previous serv
director board beckman coulter inc greatbatch inc
accuray incorpor mr wareham serv chairman
advanc medic technolog associ advam medic devic
industri trade associ mr wareham hold cum laud pharmaci
creighton univers omaha nebraska honor
washington univers st loui missouri
